New COVID-19 Variant 'Nimbus' Linked to Severe Sore Throats
The COVID-19 variant NB.1.8.1, known as 'Nimbus', is associated with painful sore throats and has been detected in travelers globally.
Overview
- The COVID-19 variant NB.1.8.1, nicknamed 'Nimbus', is causing severe sore throats described as 'razor blade' sore throats.
- By mid-May, Nimbus accounted for nearly 11% of sequenced COVID-19 samples worldwide.
- Airport screenings in the U.S. have identified Nimbus in travelers from specific regions.
- Current vaccines are expected to remain effective against the Nimbus variant, despite its painful symptoms.
- The WHO has classified Nimbus as a 'variant under monitoring', indicating a low public health risk.
Content generated by AI—learn more or report issue.
Get both sides in 5 minutes with our daily newsletter.
Analysis
Center-leaning sources frame the emergence of the Nimbus variant with a focus on its potential health impacts, emphasizing the seriousness of symptoms like painful sore throats. They convey a cautious yet reassuring tone regarding vaccine effectiveness and public health risks, reflecting a balanced perspective aimed at informing rather than alarming the audience.
Current vaccines are expected to remain effective against the Nimbus variant and other variants.
Articles (3)
Center (1)
"…Experts say there isn’t major cause for concern with the Nimbus variant, but here’s what else you need to know about it."
Associated Press·16d·FAQ
The Nimbus variant is associated with severe sore throats, often described as 'razor blade throat', along with other symptoms like nasal congestion, fatigue, mild cough, fever, muscle or body aches, headaches, diarrhea, nausea or vomiting, and less commonly, loss of taste or smell.
Yes, current vaccines are expected to remain effective against the Nimbus variant, despite its painful symptoms.
By mid-May, Nimbus accounted for nearly 11% of sequenced COVID-19 samples worldwide.
History
- This story does not have any previous versions.